These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 18448262)

  • 1. Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2008 Aug; 71(2):259-61. PubMed ID: 18448262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
    Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible link of food-derived advanced glycation end products (AGEs) to the development of diabetes.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2008 Dec; 71(6):876-8. PubMed ID: 18783891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1208-10. PubMed ID: 15823719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease.
    Yamagishi S; Nakamura K; Matsui T; Ueda S; Noda Y; Imaizumi T
    Cardiovasc Ther; 2008; 26(1):50-8. PubMed ID: 18466420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel pleiotropic effect of atorvastatin on advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H
    Med Hypotheses; 2007; 69(2):338-40. PubMed ID: 17329034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and cardiovascular disease.
    Chen Z; Boreham J
    Semin Vasc Med; 2002 Aug; 2(3):243-52. PubMed ID: 16222617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(2):392-4. PubMed ID: 15922119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel epidemiology in lung cancer - non-smokers, women and cannabis].
    Quoix E
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S10-5. PubMed ID: 18235388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Passive smoking: an environmental health risk].
    Bonneux LG; Coebergh JW
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):647-50. PubMed ID: 15106313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease.
    Bullen C
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):883-95. PubMed ID: 18570625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Eur Heart J; 2005 Sep; 26(17):1765-73. PubMed ID: 15817606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the measures of pulsatile arterial function between asymptomatic younger adult smokers and former smokers: the Bogalusa Heart Study.
    Li H; Srinivasan SR; Berenson GS
    Am J Hypertens; 2006 Sep; 19(9):897-901. PubMed ID: 16942930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived risk and interest in screening for lung cancer among current and former smokers.
    Hahn EJ; Rayens MK; Hopenhayn C; Christian WJ
    Res Nurs Health; 2006 Aug; 29(4):359-70. PubMed ID: 16847914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.